Publication | Closed Access
The Feasibility of Utilizing Plasma <em>MiRNA107</em> and <em>BACE1</em> Messenger RNA Gene Expression for Clinical Diagnosis of Amnestic Mild Cognitive Impairment
44
Citations
0
References
2015
Year
ClinicalTrials.gov identifier: NCT01819545.